Real Estate
Cofinimmo SA(CFMOF)
Live Price
Offline$93.83
+0.00% today
1Y Change
+50.89%
Window
Jun 25, 2025 โ Jun 17, 2026
- Market Cap
- $3.20B
- Revenue Growth
- -0.5%
- EPS Growth
- +229.4%
- Dividend Yield
- 7.4%
Coverage: 252 bars ยท Jun 25, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Cofinimmo SA (CFMOF) is a Real Estate stock with a market cap of $3.20B and listed on OTC. The stock last traded around $93.83 and up 50.9% across the available one-year price window (Jun 25, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of -0.5%, EPS growth of +229.4%, a dividend yield of 7.4%. What stands out right now is revenue -0.5%, EPS +229.4%, free cash flow -2.5% with operating margin 70.2% and ROIC 4.2%. The dividend matters to the case here, with a current yield around 7.4%. Valuation already assumes a fairly strong business story at P/E 15.8 and price/sales 8.1. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines CFMOF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Real Estate peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-0.5% vs +11.4% peer median
Operating Margin
Above sector median
+70.2% vs +59.6% peer median
P/E
Below sector median
15.8 vs 19.5 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 22, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -0.5% and EPS is at +229.4%, with operating margin around 70.2%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 7.4%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 22, 2026 | โ | +0.0% | +0.0% | +0.0% |
2026 Feb 20, 2026 | +146.2% | +0.0% | +0.0% | +0.0% |
2025 Oct 24, 2025 | -6.8% | +0.0% | +0.0% | +0.0% |
Benchmark Edge
CFMOF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CFMOF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CFMOF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for CFMOF and SPY.
Company Overview
Cofinimmo SA
OTC
Cofinimmo SA is a leading Belgian real estate investment trust (REIT) specializing in the acquisition, development, and management of rental properties across nine European countries, including Belgium, France, the Netherlands, Germany, Spain, Finland, Ireland, Italy, and the United Kingdom. With over 40 years of experience since its founding in 1983, the company maintains a diversified portfolio valued at approximately 6 billion EUR, with a strong emphasis on healthcare real estate comprising about 75% or 4.6 billion EUR, alongside offices and distribution network properties. Cofinimmo's mission, encapsulated in 'Caring, Living and Working - Together in Real Estate,' focuses on delivering high-quality care, living, and working spaces that benefit occupants and respond to societal needs. As an independent entity upholding top corporate governance and sustainability standards, it operates with around 150 employees across offices in Brussels, Paris, Breda, Frankfurt, and Madrid, benefiting from REIT regimes like Belgium's RREC, France's SIIC, and Spain's SOCIMI. Listed on Euronext Brussels as part of the BEL20 index and regulated by the FSMA, Cofinimmo plays a pivotal role in the European healthcare and commercial real estate sectors.
- Leadership
- Mr. Jean-Pierre Hanin
- Employees
- 150
- Street Address
- Avenue de Tervueren, Tervurenlaan 270
- Mailing
- Brussels, MI, 1150
- Region
- Brussels, MI, Belgium
- Last Updated
- May 7, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 15.8
- EV/EBITDA
- 21.7
- Price/Sales
- 8.1
- Price/Book
- 0.9
Growth
- Revenue
- -0.5%
- EPS
- +229.4%
- Free Cash Flow
- -2.5%
Profitability
- Gross Margin
- 75.4%
- Operating Margin
- 70.2%
- Net Margin
- 51.5%
- ROE
- 5.8%
- ROIC
- 4.2%
Balance Sheet
- Debt/Equity
- 0.71
- Current Ratio
- 0.12
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.